<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39455191</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2589-7500</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Lancet. Digital health</Title><ISOAbbreviation>Lancet Digit Health</ISOAbbreviation></Journal><ArticleTitle>COVID-19 testing and reporting behaviours in England across different sociodemographic groups: a population-based study using testing data and data from community prevalence surveillance surveys.</ArticleTitle><Pagination><StartPage>e778</StartPage><EndPage>e790</EndPage><MedlinePgn>e778-e790</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2589-7500(24)00169-9</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2589-7500(24)00169-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Understanding underlying mechanisms of heterogeneity in test-seeking and reporting behaviour during an infectious disease outbreak can help to protect vulnerable populations and guide equity-driven interventions. The COVID-19 pandemic probably exerted different stresses on individuals in different sociodemographic groups and ensuring fair access to and usage of COVID-19 tests was a crucial element of England's testing programme. We aimed to investigate the relationship between sociodemographic factors and COVID-19 testing behaviours in England during the COVID-19 pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We did a population-based study of COVID-19 testing behaviours with mass COVID-19 testing data for England and data from community prevalence surveillance surveys (REACT-1 and ONS-CIS) from Oct 1, 2020, to March 30, 2022. We used mass testing data for lateral flow device (LFD; data for approximately 290 million tests performed and reported) and PCR (data for approximately 107 million tests performed and returned from the laboratory) tests made available for the general public and provided by date and self-reported age and ethnicity at the lower tier local authority (LTLA) level. We also used publicly available data on mean population size estimates for individual LTLAs, and data on ethnic groups, age groups, and deprivation indices for LTLAs. We did not have access to REACT-1 or ONS-CIS prevalence data disaggregated by sex or gender. Using a mechanistic causal model to debias the PCR testing data, we obtained estimates of weekly SARS-CoV-2 prevalence by both self-reported ethnic groups and age groups for LTLAs in England. This approach to debiasing the PCR (or LFD) testing data also estimated a testing bias parameter defined as the odds of testing in infected versus not infected individuals, which would be close to zero if the likelihood of test seeking (or seeking and reporting) was the same regardless of infection status. With confirmatory PCR data, we estimated false positivity rates, sensitivity, specificity, and the rate of decline in detection probability subsequent to reporting a positive LFD for PCR tests by sociodemographic groups. We also estimated the daily incidence, allowing us to calculate the fraction of cases captured by the testing programme.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">From March, 2021 onwards, individuals in the most deprived regions reported approximately half as many LFD tests per capita as individuals in the least deprived areas (median ratio 0·50 [IQR 0·44-0·54]). During the period October, 2020, to June, 2021, PCR testing patterns showed the opposite trend, with individuals in the most deprived areas performing almost double the number of PCR tests per capita than those in the least deprived areas (1·8 [1·7-1·9]). Infection prevalences in Asian or Asian British individuals were considerably higher than those of other ethnic groups during the alpha (B.1.1.7) and omicron (B.1.1.529) BA.1 waves. Our estimates indicate that the England Pillar 2 COVID-19 testing programme detected 26-40% of all cases (including asymptomatic cases) over the study period with no consistent differences by deprivation levels or ethnic groups. Testing biases for PCR were generally higher than those for LFDs, in line with the general policy of symptomatic and asymptomatic use of these tests. Deprivation and age were associated with testing biases on average; however, the uncertainty intervals overlapped across deprivation levels, although the age-specific patterns were more distinct. We also found that ethnic minorities and older individuals were less likely to use confirmatory PCR tests through most of the pandemic and that delays in reporting a positive LFD test were possibly longer in populations self-reporting as "Black; African; Black British or Caribbean".</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Differences in testing behaviours across sociodemographic groups might be reflective of the higher costs of self-isolation to vulnerable populations, differences in test accessibility, differences in digital literacy, and differing perceptions about the utility of tests and risks posed by infection. This study shows how mass testing data can be used in conjunction with surveillance surveys to identify gaps in the uptake of public health interventions both at fine-scale levels and across sociodemographic groups. It provides a framework for monitoring local interventions and yields valuable lessons for policy makers in ensuring an equitable response to future pandemics.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">UK Health Security Agency.</AbstractText><CopyrightInformation>Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bajaj</LastName><ForeName>Sumali</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Oxford, Oxford, UK. Electronic address: sumali.bajaj@biology.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>High Meadows Environmental Institute, Princeton University, Princeton, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Creswell</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naidoo</LastName><ForeName>Reshania</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>EY Health Sciences and Wellness, London, UK; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsui</LastName><ForeName>Joseph L-H</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolade</LastName><ForeName>Olumide</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>UK Health Security Agency, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Statistics, University of Oxford, Oxford, UK; The Alan Turing Institute and Royal Statistical Society Health Data Lab, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Brieuc</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Alan Turing Institute and Royal Statistical Society Health Data Lab, London, UK; Department of Statistical Science, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Pandemic Sciences Institute, University of Oxford, Oxford, UK; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraemer</LastName><ForeName>Moritz U G</ForeName><Initials>MUG</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Oxford, Oxford, UK; Pandemic Sciences Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguas</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donnelly</LastName><ForeName>Christl A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Statistics, University of Oxford, Oxford, UK; Pandemic Sciences Institute, University of Oxford, Oxford, UK; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fowler</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UK Health Security Agency, London, UK; William Harvey Research Institute, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopkins</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UK Health Security Agency, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantrell</LastName><ForeName>Liberty</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahal</LastName><ForeName>Prabin</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Infectious Diseases Data Observatory, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Lisa J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stepniewska</LastName><ForeName>Kasia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Infectious Diseases Data Observatory, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voysey</LastName><ForeName>Merryn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Statistics, University of Oxford, Oxford, UK; College of Engineering, Mathematics and Physical Sciences, University of Exeter, Exeter, UK. Electronic address: ben.lambert@stats.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>EY-Oxford Health Analytics Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Digit Health</MedlineTA><NlmUniqueID>101751302</NlmUniqueID><ISSNLinking>2589-7500</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="Y">COVID-19 Testing</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000091569" MajorTopicYN="N">Sociodemographic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnicity</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests This work was funded by the Secretary of State for Health and Social Care acting as part of the Crown through the UKHSA, reference number C80260/PRO5331. All authors working for EY and the University of Oxford (SB, SC, RC, RN, JL-HT, OK, RA, LC, PD, LJW, KS, MV, BLa, TF, and SH) had financial support from UKHSA for the submitted work. EY has previously received payment for providing consultancy services and advice on the National Health Service Test and Trace response from the UK Department of Health and Social Care, now known as the UKHSA. SH is supported by the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance (NIHR200915), a partnership between the UKHSA and the University of Oxford. CAD declares royalties or licenses from Cambridge University Press (for a book coauthored with David Cox, Principles of Applied Statistics) and Chapman &amp; Hall/CRC Press (for a book coauthored with Neil Ferguson, Statistical Aspects of BSE and vCJD: Models for Epidemics) and other financial or non-financial interests from WHO R&amp;D Blueprint (for an unpaid position developing and evaluating possible vaccine effectiveness studies), Science Foundation Ireland (for review of grant proposals), and Singapore National Environment Agency (for participation on the Dengue Expert Advisory Panel). The views expressed in this Article are those of the authors and not necessarily those of the NIHR, UKHSA, or Department of Health and Social Care.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Aguas</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amswych</LastName><ForeName>Ma'ayan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andersen-Waine</LastName><ForeName>Billie</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bajaj</LastName><ForeName>Sumali</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bimpong</LastName><ForeName>Kweku</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bodley</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cantrell</LastName><ForeName>Liberty</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Siyu</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Creswell</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dahal</LastName><ForeName>Prabin</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dickinson</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dittrich</LastName><ForeName>Sabine</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Tracy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferguson-Lewis</LastName><ForeName>Angus</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franco</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gao</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hounsell</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kasim</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keene</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lambert</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahmood</LastName><ForeName>Umar</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mills</LastName><ForeName>Melinda</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moldokmatova</LastName><ForeName>Ainura</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Molyneux</LastName><ForeName>Sassy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Naidoo</LastName><ForeName>Reshania</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ngwafor Anye</LastName><ForeName>Randolph</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Norman</LastName><ForeName>Jared</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pan-Ngum</LastName><ForeName>Wirichada</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pokharel</LastName><ForeName>Sunil</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Polner</LastName><ForeName>Anastasiia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rowe</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saralamba</LastName><ForeName>Sompob</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shretta</LastName><ForeName>Rima</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silal</LastName><ForeName>Sheetal</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stepniewska</LastName><ForeName>Kasia</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>L-H Tsui</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Voysey</LastName><ForeName>Merryn</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wanat</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>Lisa J</ForeName><Initials>LJ</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>20</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39455191</ArticleId><ArticleId IdType="doi">10.1016/S2589-7500(24)00169-9</ArticleId><ArticleId IdType="pii">S2589-7500(24)00169-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle>